Zentek Ltd
ZTEK
Company Profile
Business description
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Contact
24 Corporate Court
GuelphONN1G 5G5
CANT: +1 705 618-0900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 March 2027
Employees
18
Stocks News & Analysis
stocks
ASX listed bank overvalued despite strong earnings
Profit beats drive shares higher for Australia’s largest asset manager.
stocks
After earnings, is Amazon a buy, a sell, or fairly valued?
After the launch of Amazon Supply Chain Services, here’s what we think of the stock.
stocks
ASX retail share expected to recover despite choppy conditions
Weakening consumer demand a temporary headwind for ASX retailer.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,942.40 | 14.50 | 0.16% |
| CAC 40 | 8,034.98 | 77.59 | -0.96% |
| DAX 40 | 24,292.05 | 46.58 | -0.19% |
| Dow JONES (US) | 49,633.28 | 24.12 | 0.05% |
| FTSE 100 | 10,267.43 | 34.36 | 0.34% |
| HKSE | 26,406.84 | 13.13 | 0.05% |
| NASDAQ | 26,249.24 | 2.17 | 0.01% |
| Nikkei 225 | 62,417.88 | 295.77 | -0.47% |
| NZX 50 Index | 13,210.48 | 35.35 | 0.27% |
| S&P 500 | 7,411.17 | 12.24 | 0.17% |
| S&P/ASX 200 | 8,701.80 | 11.50 | 0.13% |
| SSE Composite Index | 4,225.02 | 45.07 | 1.08% |